Tag: Epidemic

Categories
Health

The epidemic will sweep throughout the U.S. at completely different occasions, Dr. Scott Gottlieb says

The epidemic will sweep across the U.S. at different times, Dr. Scott Gottlieb says

Dr. Scott Gottlieb told CNBC that he expects surging U.S. coronavirus cases, linked to the highly transmissible delta variant, to start decreasing in just a few weeks. 

“Probably, in two or three weeks, I think that we were probably about three weeks behind the U.K.,” said the former FDA chief in the Trump administration.  

“The U.K. clearly is on a downslope…I would expect some of the southern states that really were the epicenter of this epidemic to start rolling over in the next two or three weeks.”

While the epidemic is still expanding across southern states, the rate of expansion is showing signs slowing. Gottlieb told “The News with Shepard Smith” that the slowdown is a sign that those southern states may be reaching their peak. 

Gottlieb did warn, however, that northern states may start to see more delta spread, as rates decrease in the south. 

“Here, in this country, it’s going to be much more regionalized now, I don’t expect the density of the spread of delta in states like New York or Michigan to be what it was in the south,” Gottlieb said. “We have more vaccine coverage, up there, we’ve had more prior infection, but you will see an uptick in cases, even in states where there is a lot of vaccine coverage, probably just not as severe.” 

Disclosure: Scott Gottlieb is a CNBC contributor and is a member of the boards of Pfizer, genetic testing start-up Tempus, health-care tech company Aetion Inc. and biotech company Illumina. He also serves as co-chair of Norwegian Cruise Line Holdings’ and Royal Caribbean’s “Healthy Sail Panel.”

Categories
Health

Docs name for flu testing as Covid threatens to coincide with flu epidemic

Doctors call for flu testing as Covid threatens to coincide with flu epidemic

British doctors have urged authorities to make flu testing available amid concerns that an influenza epidemic may be about to collide with a third wave of Covid-19.

In a report published Thursday, physicians from the U.K.’s Academy of Medical Sciences warned a resurgence of respiratory viruses such as flu and RSV — a common virus that can be serious for young infants and the elderly — was likely to increase pressure on the country’s National Health Service.

The U.K. is due to lift nearly all Covid restrictions on July 19. However, the country is currently experiencing a rise in new cases of the virus, which has been linked to the highly transmissible delta variant.

On July 14, 42,302 people tested positive for Covid in the U.K., making it the country with the fourth-highest number of new cases, according to Johns Hopkins University. 

Doctors warned in Thursday’s report that overlapping symptoms between flu and Covid meant routine testing for both viruses, and possibly additional respiratory infections — known as multiplex testing — would be important ahead of an expected uptick in common winter illnesses. Medical experts have expressed concerns the U.K. could be headed for an influenza epidemic later this year, and multiplex testing would help doctors differentiate between viruses, allow them to monitor the growth of epidemics, make timely decisions about treatments and reduce transmission rates, the report said.

“We strongly support multiplex testing,” its authors said. “However, if this is not feasible, well evaluated and accurate point-of-care testing for influenza should be deployed in hospitals, primary care settings, care homes and community pharmacies.”

They added that “the symptoms of influenza and other winter respiratory viruses are typically clinically indistinguishable from Covid-19 without a test,” and warned demand for PCR tests may surge this year given the potential rise in winter diseases with similar symptoms.

A recent study of Covid symptoms in the U.K. found that the most common symptoms of the virus included a headache, sore throat and loss of smell. However, these can vary and people with the virus can also experience flu-like symptoms such as fever and a cough, according to the U.S. Centers for Disease Control and Prevention and the U.K.’s NHS.

The AMS noted that while a successful vaccine rollout would mean mortality would be lower in the next wave than in the winter of 2020/2021, continuous transmission of Covid among the under-50s could result in higher levels of “long Covid” than seen in the previous two waves. The medical body also warned that if Covid cases rise or remain elevated throughout the fall and winter, the third wave could coincide with a resurgence of flu and RSV, adding pressure to the NHS.

Outbreaks of RSV and flu during the fall and winter may be twice as large as the numbers seen in a “normal” year, according to the report. Social distancing and lockdown measures had prevented these illnesses from spreading at their usual rates during the coronavirus pandemic, meaning population immunity may have been diminished.  

“Very low levels of influenza over the last two seasons will have led to lower levels of immunity than usually seen, which means a wave of influenza could be problematic,” the report warned. A priority should be to ensure vulnerable groups were given a flu vaccine, its authors said, although flu vaccines were less effective than those for Covid.

Around 10,000 deaths are caused by flu in a regular year in England and Wales, according to the NHS.

Meanwhile, non-infectious illnesses like asthma and stroke were also likely to be exacerbated in the winter, the AMS report warned, adding more pressure to health care services.

Categories
Health

U.S. unlikely to have one other ‘raging epidemic,’ Gottlieb says

U.S. unlikely to have another ‘raging epidemic,’ Gottlieb says

Dr. Scott Gottlieb told CNBC on Wednesday that he believes there is enough Covid immunity protection throughout the U.S. population that even if the highly transmissible Delta variant is in circulation, the country is unlikely to experience anywhere near as dire like previous points of the pandemic.

“I don’t think there’s going to be a raging epidemic across the country like we saw last winter. I think there will be niches of spread and the overall prevalence will increase, “said the former Commissioner of the Food and Drug Administration said on” Squawk Box. ”

“But I think that in parts of the country where vaccination rates are high, and that certainly applies to the northeast, in my opinion we are largely protected – at least from the current variants that are in circulation,” added board member Gottlieb of Covid Vaccine manufacturer Pfizer.

On the other hand, Gottlieb said parts of the country are more prone to outbreaks with the Covid Delta variant. These are places where the number of people who have previously been infected or vaccinated is low. He highlighted the situation in Missouri, where health officials have raised concerns about spikes in cases and hospital admissions, particularly in areas with lagging vaccination rates.

“If you are someone who has even been vaccinated in these parts of the country and there is a heavy epidemic of this new variant of the Delta, you are also at risk because we know the vaccines are not 100% and we know it. ” In vulnerable populations – people with compromised immune systems, people who are much older – the vaccines may not work as well over time. “

First found in India, the Delta variant has been identified in more than 90 countries, including the United States, where its prevalence doubles roughly every two weeks. In some countries, such as Israel, concerns about the Delta variant have led governments to tighten public health restrictions.

The UK postponed the most recent phase of its economic reopening earlier this month, citing the pace of new Delta variant infections and an increase in hospital admissions. Most of the cases involved unvaccinated people.

Los Angeles County officials released guidelines for inner masks this week, including those for fully vaccinated individuals, amid concerns about the Delta variant. It comes roughly two weeks after the county joined the state of California to lift mask requirements for fully vaccinated individuals indoors in most environments.

The World Health Organization on Friday also urged fully vaccinated people to continue wearing face masks, and officials said it was necessary to “play it safe” as many parts of the world are still unvaccinated.

“The goal should be to try to reduce transmission as much as possible here in the United States. I think we shouldn’t be rash,” said Gottlieb, who headed the FDA in the Trump administration from 2017 to 2019 . “But we will see that the overall impact of the virus will be greatly reduced because so many people have been vaccinated.”

In the United States, around 154.2 million people, or 46.4% of the population, are fully vaccinated, according to the Centers for Disease Control and Prevention. Almost 180 million people, or 54.2% of the country’s population, have received at least one dose.

According to a CNBC analysis of Johns Hopkins University data, there are an average of around 12,400 new coronavirus cases per day in the United States, based on an average of seven days. That is 10% more than a week ago. The daily average of Covid deaths fell 7% to 278 per day over the same period.

Despite the increase in cases, Gottlieb said he believed US public health officials should be cautious about reintroducing pandemic restrictions right now. Daily new infections remain dramatically lower than their daily high in the US of 300,462 on Jan. 2, according to Johns Hopkins data.

“I think the right response is first and foremost to have more people vaccinated,” said Gottlieb. “We have just got to a point where our mitigation should be really reactive, not proactive,” he added. “We shouldn’t shut things up or put off mask requirements in anticipation of spread. I think we should do this when we see signs of spread, signs of outbreaks. “

Disclosure: Scott Gottlieb is a CNBC employee and a member of the board of directors of Pfizer, genetic testing startup Tempus, health technology company Aetion Inc., and biotechnology company Illumina. He is also co-chair of the Healthy Sail Panel of Norwegian Cruise Line Holdings and Royal Caribbean.

Categories
Health

A Coronavirus Epidemic Hit 20,000 Years In the past, New Research Finds

A Coronavirus Epidemic Hit 20,000 Years Ago, New Study Finds

Researchers have found evidence that a coronavirus epidemic swept East Asia about 20,000 years ago and was devastating enough to leave an evolutionary imprint on the DNA of people living today.

The new study suggests that the region was plagued by an ancient coronavirus for many years, researchers say. The finding could have devastating effects on the Covid-19 pandemic if it is not brought under control soon with vaccinations.

“It should worry us,” said David Enard, an evolutionary biologist at the University of Arizona who led the study, which was published Thursday in the journal Current Biology. “What is happening now could last for generations.”

So far, researchers have not been able to look very far back into the history of this family of pathogens. Over the past 20 years, three coronaviruses have adapted to infect people and cause serious respiratory illnesses: Covid-19, SARS, and MERS. Studies on each of these coronaviruses suggest that they jumped into our species from bats or other mammals.

Four other coronaviruses can also infect people, but usually only cause mild colds. Scientists didn’t directly observe how these coronaviruses became human pathogens, so they relied on indirect clues to gauge when the jumps happened. Coronaviruses acquire new mutations at roughly regular rates, and so by comparing their genetic variation it can be determined when they deviated from a common ancestor.

The youngest of these mild coronaviruses, called HCoV-HKU1, crossed species boundary in the 1950s. The oldest, called HCoV-NL63, can be up to 820 years old.

But before that, the coronavirus trail got cold – until Dr. Enard and his colleagues applied a new method to the search. Instead of looking at the coronavirus genes, the researchers looked at the effects on the DNA of their human hosts.

Viruses cause enormous changes in the human genome over generations. A mutation that protects against a viral infection can make the difference between life and death and is passed on to the offspring. For example, a life-saving mutation could allow humans to hack up the proteins of a virus.

But viruses can also develop. Your proteins can change shape to overcome a host’s defenses. And these changes could spur the host to develop even more counter-offensives, which leads to more mutations.

If a random new mutation creates resistance to a virus, it can quickly become more common from one generation to the next. And other versions of this gene are becoming rarer. So if, in large groups of people, one version of a gene dominates all the others, scientists know that it is most likely a sign of rapid evolution in the past.

In recent years, Dr. Enard and his colleagues searched the human genome for these genetic variation patterns to reconstruct the history of a number of viruses. When the pandemic broke out, he wondered if ancient coronaviruses had left their own mark.

He and his colleagues compared the DNA of thousands of people from 26 different populations around the world, looking at a combination of genes known to be critical for coronaviruses but not other types of pathogens. In East Asian populations, the scientists found that 42 of these genes had a dominant version. That was a strong signal that people in East Asia had adapted to an ancient coronavirus.

But whatever happened in East Asia seemed to be confined to that region. “When we compared them to populations around the world, we couldn’t find the signal,” said Yassine Souilmi, postdoctoral fellow at the University of Adelaide in Australia and co-author of the new study.

The scientists then tried to estimate how long East Asians had already adapted to a coronavirus. They took advantage of the fact that once a dominant version of a gene begins to be passed down through the generations, it can acquire harmless random mutations. The more time passes, the more of these mutations accumulate.

Dr. Enard and his colleagues found that all 42 genes had about the same number of mutations. That meant they had all evolved rapidly at about the same time. “This is a signal that we should definitely not expect by chance,” said Dr. Enard.

They estimated that all of these genes developed their antiviral mutations sometime between 20,000 and 25,000 years ago, most likely over the course of a few centuries. This is a surprising finding, since the East Asians did not live in dense communities at the time, but rather formed small groups of hunters and gatherers.

Aida Andres, an evolutionary geneticist at University College London who was not involved in the new study, said she found the work compelling. “I’m pretty sure there is something,” she said.

Still, she didn’t think it was possible to give an accurate estimate of how long ago the ancient epidemic was. “Timing is a complicated thing,” she said. “Whether that happened a few thousand years before or after – I personally think that we can’t be so sure about it.”

Scientists looking for drugs to fight the new coronavirus may want to study the 42 genes that evolved in response to the old epidemic, said Dr. Souilmi. “It actually points us out to molecular buttons to adjust the immune response to the virus,” he said.

Dr. Anders agreed, saying that the genes identified in the new study should receive special attention as drug targets. “You know they are important,” she said. “That’s the beauty of evolution.”

Categories
Business

We are able to vaccinate our method out of this epidemic if all adults get photographs, says physician

J&J asked Pfizer, Moderna to help study blood clots but they declined: WSJ

Daylight saving time in the United States could return to pre-Covid-19 normal if 75% to 80% of the US population are vaccinated, said Dr. Peter Hotez on Friday.

“We can vaccinate out of this epidemic if all adults and adolescents are vaccinated by summer. We can have an exceptional quality of life by returning to concerts and music events, as well as ball games, bars, restaurants, clubs and clubs.” all the things we like to do so we have to work towards them, “said Hotez.

Hotez, co-director of the vaccine development center at Texas Children’s Hospital, told CNBC’s The News with Shepard Smith that vaccine hesitation will prevent the US from getting 75% to 80% of the population vaccinated.

The demand for the Covid-19 vaccine has fallen in all states. Louisiana, for example, asked for fewer cans because the demand was so low. Polls show that more than 40% of Republicans do not plan to vaccinate, and Hotez advised health professionals to reach out to conservative groups to help protect the entire US population.

“About 40% to 45% of Republicans say they may not or may not take the vaccine, and when you add the numbers that’s about 10% of the adult population,” Hotez said. “There we have to work harder to reach conservative groups … that we have to fix.”

Categories
Health

Might the Pandemic Immediate an ‘Epidemic of Loss’ of Ladies within the Sciences?

Could the Pandemic Prompt an ‘Epidemic of Loss’ of Women in the Sciences?

Like many women during the pandemic, Alisa Stephens found working from home to be a series of tired challenges.

Dr. Stephens is a biostatistician at the University of Pennsylvania, and the technical and detail-oriented nature of her work requires long, uninterrupted deliberation. Finding the time and mental space to do this work at home with two young children proved impossible.

“That first month was really tough,” she recalled of the lockdown. Her young daughter’s daycare was closed and her 5-year-old was at home instead of school. Since her nanny could not come into the house, Dr. Stephens looked after her kids all day and worked late into the evening. Schools did not reopen in the fall, when her daughter was about to start kindergarten.

Things relaxed when the family was sure to bring in a nanny, but there was little time for the deep thought that Dr. Stephens had left every morning for work. Over time, she has adjusted her expectations of herself.

“Maybe I’m 80 percent versus 100 percent, but I can get things done at 80 percent to some degree,” she said. “It’s not great, it’s not my best, but it’s enough for now.”

Dr. Stephens is in good company. Several studies have found that women published fewer articles, conducted fewer clinical trials, and received less recognition for their expertise during the pandemic.

Add to this the emotional upheaval and stress of the pandemic, protests against structural racism, concerns about children’s mental health and education, and lack of time to think or work, and an already unsustainable situation becomes unbearable.

“The confluence of all these factors creates this perfect storm. People are at their breaking point, ”said Michelle Cardel, an obesity researcher at the University of Florida. “My great fear is that we will have a secondary epidemic of losses, especially from women in early STEM careers.”

Women scientists had problems even before the pandemic. It wasn’t uncommon for her to hear that women weren’t as smart as men, or that a woman who was successful must have received a handout along the way, said Daniela Witten, biostatistician at the University of Washington in Seattle. Some things are changing, she said, but only with great effort and at an Ice Age pace.

The career ladder is particularly steep for mothers. Even while on maternity leave, they are expected to keep up with laboratory work, teaching requirements, publications, and mentoring PhD students. When they return to work, most of them do not have affordable childcare.

Women in science often have little recourse when faced with discrimination. Your institutions sometimes lack the staffing structures that are common in the business world.

The road is even more difficult for color scientists like Dr. Stephens, who encountered other prejudices in the workplace – from everyday reactions, professional reviews or promotions – and now dealing with the disproportionate impact of the pandemic on black and Latin American communities.

Dr. Stephens said a close friend, also a black scientist, has five family members who have contracted Covid-19.

Updated

April 13, 2021, 6:10 p.m. ET

The year was a “break” for everyone, added Dr. Stephens added, and universities should find a way to help scientists when the pandemic ends – perhaps by adding an extra year to the time they have to earn a tenure.

Others said while additional tenure may help, it will now be far from enough.

“It’s like you’re drowning and the university is telling you, ‘Don’t worry if you need an extra year to get back on land,” said Dr. Witten. “It’s like,’ Hey, that is not helpful. I need a flotation device. ‘”

The frustration is compounded by outdated ideas about how to help women in science. But social media has allowed women to share some of those concerns and find allies to organize and exclaim injustices when they see this, said Jessica Hamerman, an immunologist at the Benaroya Research Institute in Seattle. “It’s just a lot less likely that people will sit still and hear biased statements that concern them.”

In November, for example, the influential journal Nature Communications published a controversial study on women scientists, suggesting that female mentors would hinder the careers of young scientists and recommending that young women seek men to help them instead.

The reaction was intense and unforgiving.

Hundreds of scientists, men and women, abandoned the paper’s flawed methods and conclusions, saying they had reinforced outdated stereotypes and failed to account for structural biases in science.

“The advice from the newspaper was essentially similar to the advice your grandmother gave you 50 years ago: get a man to look after you and you’ll be fine,” said Dr. Cardel.

Nearly 7,600 scientists signed a petition asking the journal to withdraw the paper – which it did on December 21st.

Class disturbed

Updated March 29, 2021

The latest on how the pandemic is changing education.

The study came at a time when many women scientists were already concerned about the impact of the pandemic on their careers and were already nervous and angry about a system that offered them little support.

“It was an incredibly difficult time being a woman in science,” said Leslie Vosshall, a neuroscientist at Rockefeller University in New York. “We’re already down, we’re already on our knees – and then the newspaper comes and kicks us to say, ‘We have the solution, let’s take the PhD students to an older man.'”

Some people on Twitter suggested that the Nature Communications paper had been withdrawn because a “feminist mob” requested it, but in fact the paper was “a dumpster fire of data,” said Dr. Vosshall.

According to several statisticians, the study was based on incorrect assumptions and statistical analyzes. (The authors of the paper declined to comment.)

Dr. Vosshall said she felt compelled to push back because the paper was “dangerous”. Department heads and deans of medical faculties have used the research to direct doctoral students to male mentors and to roll back all advances in equality of science. She said, “The older I get, the more windows I have for this job that really works.”

She used some of her wisdom to bring about change at Rockefeller University, one of the oldest research institutions in the country.

A few years ago Rockefeller University invited news anchor Rachel Maddow to present a prestigious award. On the way into the auditorium, Ms. Maddow pointed to a wall adorned with pictures of Lasker Prize and Nobel Prize winners – all men – who were affiliated with the university. At least four women at the university had also won prestigious awards, but their photos were not on display.

“What’s up with the guy wall?” Mrs. Maddow asked. And Dr. Vosshall, who had walked past the wall a thousand times, suddenly saw it differently. She realized that it was sending the wrong message to all the high school students, undergraduates, and graduate students who routinely walked by it.

“As soon as you notice a guy wall, you see them everywhere,” she said. “They are in every auditorium, in every corridor, in every departmental office, in every conference room.”

Rockefeller University eventually agreed to replace the display with a display more representative of the institution’s history. The pictures were taken on November 11th, announced Dr. Vosshall on Twitter and will be replaced with a more comprehensive set.

The departments at Yale University and Brigham and Women’s Hospital in Boston have also rethought their buddy walls, said Dr. Vosshall. “There are some traditions that shouldn’t be perpetuated.”

Categories
Health

Sacklers Deny Private Accountability for Opioid Epidemic in Home Listening to

Sacklers Deny Personal Responsibility for Opioid Epidemic in House Hearing

Members of Congress on Thursday threw withering comments and angry questions at two members of the Sackler billionaire family who own Purdue Pharma, the maker of OxyContin, in a rare public appearance to take personal responsibility for the deadly opioid epidemic for details over $ 10 billion showing the family withdrew from the company.

The hearing before the House Oversight Committee provided the public with an extremely unusual opportunity to hear directly from some family members whose company is accused in thousands of federal and state lawsuits for misleading marketing of OxyContin, the pain reliever seen as initiating a wave of opioid addiction, which resulted in the deaths of more than 450,000 Americans. Eight family members were individually named in many state cases.

The uniqueness of the Sacklers’ appearance on Thursday was underscored by the likelihood that they will never testify in court, as the ongoing bankruptcy proceedings and statewide litigation can be settled in settlements rather than legal proceedings. Despite the millions of dollars in legal costs incurred by plaintiffs and Purdue alike – and the subsequent Chapter 11 filing for bankruptcy protection in September 2019 – one obstacle to resolution remains: the Sacklers refusal to face personal or criminal accountability and appeal over substantial parts of their property.

During the tense, nearly four-hour hearing, 40-year-old David Sackler and his cousin Dr. Kathe Sackler (72), who both worked for years on the company’s board of directors, testified from a distance and largely avoided the possible booby-traps and diverted the blame for “management” and independent, non-family board members.

Or, as Mr Sackler said, “That is a question for the lawyers.”

Repeatedly, committee members pitted harsh statistics on the destruction from the epidemic against pictures of the family’s simultaneous gains, including a $ 22.5 million mansion in the Bel Air neighborhood of Los Angeles paid in cash in 2018 – which David did Sackler called an investment in which he had not spent a single night.

Throughout the session, both Sacklers expressed regret over OxyContin’s role in the epidemic, but not about their own actions over the years when the company aggressively promoted the pain reliever, with the oversight and encouragement of the board of directors.

In fact, Dr. Sackler embarrassed about patient welfare. “I thought Purdue was acting responsibly to reduce the incidence of abuse and overdose while continuing to serve those in need of pain relief,” she said.

“I was trying to find out, was there anything I could have done differently? Know what I knew then – not what I know now? “Said Dr. Sackler, who served on the board from 1990 to 2018. “There is nothing that I could find otherwise, depending on what I believed and understood at the time.”

She said what she later learned from management and reported to the board was “extremely distressing.”

Mr. Sackler, who served on the board from 2012 to 2018, was similarly sensitive: “I believe I behaved legally and ethically, and I believe the full record will show that I still feel absolutely awful that a product created to help so many people “is linked to death and addiction, he said.

Deeply skeptical committee members asked the Sacklers whether they actually subscribed to newspapers or had access to cable television.

Speaking to the Sacklers, Representative Jim Cooper, Democrat of Tennessee, said, “When I see you testify, my blood boils. I don’t know of any family in America worse than yours. “

West Virginia Republican Carol Miller asked Mr. Sackler if he had ever visited Appalachia to see firsthand the effects of the crisis.

“Yes,” he replied, but not for the express purpose of establishing the facts.

“I was on vacation with my wife,” he said.

In the absence of a direct sense of responsibility by the Sacklers – or by Dr. Craig Landau, Purdue’s chief executive officer since 2017, who also testified – the committee members used their questions to explain the most egregious actions of the company and Dr. Sackler’s father, Dr. Richard Sackler, a practical manager during the height of the epidemic.

In particular, they examined the measures resulting from a nearly $ 635 million fine in 2007 paid by the company and three senior executives after pleading guilty of “misbranding”. The settlement did not include any assumption of liability by one of the Sacklers.

The committee chairman, Representative Carolyn B. Maloney, Democrat of New York, asked Mr. Sackler if the family was concerned about a government investigation following the company’s federal settlement in 2008. Mr. Sackler denied knowing that the investigation had increased.

But then Ms. Maloney read from an email exchange between Mr. Sackler and other relatives in 2007, just a week after that settlement. Regarding courtroom activities, he wrote, “We are rich? For how long? Until what suits reach the family? “

Then she asked Mr. Sackler, “Have you tried to cash out winnings so opioid victims can’t claim them for future losses?”

He replied: “No, I don’t think that’s what I meant then.”

The committee was able to require the Sacklers to submit a list of the companies Ms. Maloney referred to as “offshore shell companies”. According to court records, the family withdrew approximately $ 10 billion from Purdue Pharma between 2008 and 2017.

Mr Sackler said Thursday that the family paid about half of those taxes.

Dr. Landau said that during his tenure the company stopped promoting opioids and focused on developing drugs that reverse overdoses.

Three generations of family members have overseen Purdue since the 1950s when three brothers – including Raymond (David’s grandfather) and Mortimer (Kather’s father) – started it. (A third brother, Dr. Arthur Sackler, sold his stock long before OxyContin was launched.) During the opioid epidemic, family members served on Purdue’s board of directors, often pushing the sales department to rave about – prescribing doctors and downplaying its addictive properties of the drug according to extensive court documents.

Last month, Purdue pleaded guilty to three crimes of setbacks and fraud related to advertising its opioid and failing to report abnormal sales. The Justice Department has agreed with the company $ 8.3 billion in criminal and civil penalties and family members with $ 225 million in civil penalties. The Sacklers did not admit any wrongdoing. The amount they paid is roughly 2 percent of the family’s net worth.

Maura Healey, the attorney general of Massachusetts, the first state to name individual Sacklers in litigation, said the Sacklers want “special treatment.” In a letter to the House Committee, she wrote, “If we let powerful people cover up the facts, avoid accountability, or start a government sponsored OxyContin business – it is no justice. This time we have to get it right. “

In 2019, Congressman Elijah E Cummings, the late committee chairman, opened an investigation into the company and the family to see if their actions should lead to possible policy or legislation changes. In October, the committee released a plethora of documents that underscored how individual Sacklers asked the company to increase sales. The committee tried to get numerous Sacklers to testify, which they opposed through their lawyers, saying that the appearances would hamper the ongoing bankruptcy process.

The committee’s lawyers threatened to summon them. After considerable disputes, the Sacklers agreed to introduce two of the four family members originally requested.